Eli Lilly and Company
A drug company based in the United States. It is the lead sponsor of the SURPASS-CVOT trial, a collaborator on four SGLT2 inhibitor trials led by Boehringer Ingelheim, and the applicant and listed manufacturer for Mounjaro.
Also called Eli Lilly · Lilly · ELI LILLY AND CO
- Organization
- In this atlas
Overview
Technical summary
ROR 01qat3289. ClinicalTrials.gov lists Eli Lilly and Company as lead sponsor of NCT04255433 (SURPASS-CVOT) and as a collaborator on NCT01131676 (EMPA-REG OUTCOME), NCT03594110 (EMPA-KIDNEY), NCT03057977 (EMPEROR-Reduced) and NCT03057951 (EMPEROR-Preserved). The openFDA record for NDA215866 lists the sponsor as ELI LILLY AND CO and the manufacturer name as Eli Lilly and Company.
Roles
- Company
Sector
Industry
Record details
- Record id
cardio:eli-lilly- Content hash
d7c3892a0a7ece7e99d4d34dfcef2e62a5b2221a84779b33b94bb09d549aae62